1. No category

Global Hepatitis B
Diagnostic Test
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016-2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
Hepatitis B is an infectious disease associated with the inflammation of the liver. Hepatitis B
infection is caused due to the Hepatitis B virus (HBV) transmitted from one person to other
through infectious blood, semen and other body fluids. Hepatitis B infection can be acute and it
may develop into chronic infection if not diagnosed and treated at an early stage. Chronically
infected Hepatitis B patients eventually develop liver cirrhosis, hepatocellular carcinoma (liver
cancer), fulminant hepatitis B (autoimmune disorder) or suffer from liver failure requiring liver
transplant and can even result in death. In 2014, out of the 360 Mn people infected with
hepatitis B worldwide, around 1 Mn people died of the disease or other complications
associated with it. However, there is a significant decrease in incidence of hepatitis B after
introduction of hepatitis B vaccine. Diagnosis of HBV is achieved by performing several tests for
serological markers of HBV such as HBsAg, anti-HBs antibodies, HBeAg, anti-HBe antibodies and
anti-HBV core antibodies. Currently, nucleic acid testing for HBV DNA is used to detect the
hepatitis B viral load. The diagnosis of hepatitis B involves collection of blood samples followed
by the detection of viral antigens and antibodies in either serum or plasma.
Hepatitis B Diagnostic Test Market: Drivers and Restraints
In vitro diagnostics is the vital market for the hepatitis B diagnostic test as the serological
markers from blood are tested outside the body in the laboratory. Increasing prevalence and
incidence of hepatitis B worldwide and multitude of available tests are the major drivers for the
increasing growth of global hepatitis B diagnostic test market.
Report
Description
Report Description
Increasing public awareness and understanding of viral hepatitis, promotion of wider access to
monitoring and screening procedures by several countries as a part of national program and
introduction of evidence based policies are anticipated to aid the growth of global hepatitis B
diagnostic tests market. However, complexity of clinical management and lack of coordination
between clinicians and laboratory personnel to decide choice of assay employing appropriate
hepatitis B diagnostic test will remain some of the major restraints for the global hepatitis B
diagnostic test market.
Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1332
Hepatitis B Diagnostic Test Market: Segmentation
The global hepatitis B diagnostic tests market is classified on the basis of test type, technique
end use and geography.
Based on test type, the global hepatitis B diagnostic test market is segmented into the following:
Hepatitis B surface antigen test (HBsAg)
Anti-hepatitis B surface antibody test
Hepatitis B core antigen test (HBcAb)
Anti-hepatitis B core antibody test
HBV DNA test
Others
Report
Description
Report Description
Based on techniques, the global hepatitis B diagnostic test market is segmented into the
following:
PCR
Radioimmunoassay (RIA)
Enzyme-linked immunosorbent assay (ELISA)
Others
Based on end use type, the global hepatitis B diagnostic test market is segmented into the
following:
Hospitals
Diagnostic centers
Clinics
Hepatitis B Diagnostic Test Market: Overview
More than 13 immunoassays are available for the diagnosis of hepatitis B at an early stage.
They can also be used to distinguish acute and chronic hepatitis B infections. Global market
for HBsAg test is expected to drive the greater revenue generation as it the preliminary test
for the detection of HBV in the blood of infected person and also the test is ordered for
many of the blood donors prior to blood donation.
Report
Description
Report Description
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1332
Hepatitis B Diagnostic Test Market: Regional Overview
Geographically, the global hepatitis B diagnostic tests market is classified into regions
namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan,
Middle East and Africa. North America is expected to be the key region in global hepatitis
diagnostic tests market followed by Asia-Pacific and Europe. Availability of good
reimbursement policies for diagnostic tests in many of the high income countries in Europe
is expected to keep up the market for hepatitis B diagnostic testsin nearest future.
Hepatitis B Diagnostic Test Market: Key Players
Some of the key players providing diagnostic tests for hepatitis B are MedMira Inc, Abbott
Laboratories, Inovio pharmaceuticals Inc., Siemens Healthcare GmbH, Innovita biological
technology Co. Ltd., Assure Tech. (Hangzhou) Co. Ltd., Nantong Diagnos biotechnology Co.
Ltd., Blue Cross Bio-Medical (Beijing) Co. Ltd., BioGenex., Abnova Corporation etc.
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705